article thumbnail

The end-of-life care conundrum

pharmaphorum

At the same time, the pharmaceutical industry is creating a greater number of oncology treatments that could provide breakthroughs for patients where none previously existed. Ben Hargreaves examines why there is no easy answer to the question of when palliative care is the right option for patients. The rise of immunotherapies.

article thumbnail

Navigating the rapidly changing oncology treatment landscape: how digital tools can help

Impetus Digital

In fact, for the past five years, the number of treated patients with cancer has seen an average annual increase of 5% globally (1). This competitive intensity tends to focus on smaller patient populations with multiple treatment options (1,2). However, with rapid growth comes growing pains.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Living the life of a type 2 diabetes patient for a day

pharmaphorum

Mark Doyle, co-founder of The Method and creator of the A Life in a Day programme, tells us about the immersive experience he and his team created that allows anyone to live the life of a type 2 diabetes patient for 24 hours. Becoming a diabetes patient. Becoming a diabetes patient.

article thumbnail

Top 12 Healthcare Technology Start-ups To Know

Medico Reach

Founder: Eric Lefkofsky Year of establishment: 2015 Headquarters: Chicago, Illinois. Tempus began with the goal of incorporating artificial intelligence and data science into the healthcare industry. Additionally, the company’s dedication to providing precision medication during the pandemic put it on CNBC’s Disruptor 50 list.

article thumbnail

FDA drops PreCert report, new digital health guidances

pharmaphorum

I think that in many cases with digital therapeutics, you also do have something of a recommendation to go with them, [with regards] to which patients is this going to work well for?” O’Leary said. New SaMD guidance and more.

FDA 129
article thumbnail

Harnessing the Power of Generational Diversity as a Competitive Advantage

PM360

Today’s workforce includes Traditionalists (born 1927-1945), Boomers (1946-1964), Gen X (1965-1980), Millennials (1981-1996), and Gen Z (1997-2015). Patients are more motivated to pay attention, act, and follow a treatment plan when they recognize themselves in the marketing.

article thumbnail

Digital health tech: a solution to substance use disorders?

Pharmaceutical Technology

Healthcare providers are under pressure to address the growing issue of substance use disorders. A recent study in the Journal of the American Medical Association found that between 2015 and 2019 as high as one in eight deaths in the US could be attributable to excessive alcohol consumption.